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• 
Cutaneous lymphomas (CL) are rare in pediatric patients and are mostly represented by mycosis 
fungoides and CD30+ lymphoproliferative disorders (lymphomatoid papulosis [LYP] and 
anaplastic large T-celllymphoma [ALCL]). CL in children should be differentiated from benign 
skin disorders. 
The purpose of our study was to investigate the role of T-celI receptor analysis by using the 
BIOMED-l and BIOMED-2 primer sets for complete and incomplete TCR delta, gamma and 
beta rearrangements. We coHected DNA samples from frozen skin biopsies of 31 patients less 
than 18 years of age: 7 mycosis fungoides (MF), 8 parapsoriasis (PS), lO LYP and 2 ALCL, 2 
subcutaneous panniculitis-like CD8+ a:p T-celllymphoma (SPTL) and 2 CD4+ small/medium­
sized pleomorphic T-celllymphoma (PTL). 
AH MF and 2/8 parapsoriasis presented clonaI rearrangements. In the CD30+ lymphomas, clonaI 
rearrangements were observed in 9/10 LyP and 1/2 ALCL. Four pediatric patients, presented rare 
entities (SPTL and PTL) and aH cases were clonai. The presence of a T-celI clone was confirmed 
by sequencing in 17 patients. In one MF case, we detected the presence ofthe same clone in skin 
and peripheral blood, while in 2 cases (PTL and PS) different clones were found in different skin 
biopsies. Overall, we found clonaI rearrangements in 23 patients, confirmed by sequencing of the 
TCR genes in 17/23. These data suggest the higher sensitivity ofthe more complete screening 
(delta, gamma and beta) and the utility ofthe sequencing procedures. FinaHy some MF, LYP, 
CD30+ aggressive cases were studied by arrays-CGH showing alterations of the genome in three 
cases, such as: trisomy of chromosome 7 (CD30+) and 19 (CD8+); duplication of 22 (CD8+); 
deletion of TCRND (SPTL). No genomic imbalance were demonstrated in the analyzed cases of 
PS or LYP. Three of our patients died of disease: one ofMF progressing to erythroderma, blood 
and lymph nodes; the second of SPTL complicated by haemophagocytic syndrome; the third of 
CD30+, CD8+ ALCL for dissemination and visceral involvement. 
Due to the highly' variable presentations of these malignancies and to the relevance of prognostic 
issues in children, we conclude that molecular assessment can be very important to improve 
diagnosis ofthese diseases. 
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